Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Subcutaneous Tocilizumab in Adults With Severe and Critical Covid-19: A Prospective Open-Label Uncontrolled Multicenter Trial
Mohammad Vodjgani
Mohammad Vodjgani

Professor of Medical Immunology

Department Immunology

School of Medicine

Translational Ophthalmology Research Center

Tehran University of Medical Sciences

All Documents